Hanmi Pharm Chairman Lim Sung-ki was nominated Asia's Best CEO from Institutional Investor magazine.
In a ceremony held in Hanmi Headquarters in Seoul, Lim was given the CEO honor in the healthcare and pharmaceuticals sector by Wendy Gallagher, a publisher of Asia's Institutional Investor magazine.
Institutional Investor is a leading international business to business publisher, focused p...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.